|
FY2026
12 months to Jul 31, 2026
|
FY2025
12 months to Jul 31, 2025
|
|
|---|---|---|
| Revenue | ||
| Cost and expenses: | ||
| Cost of revenue | ||
| General and administrative expenses | ||
| Research and development expenses | ||
| Sales and marketing expenses | ||
| Total cost and expenses | ||
| (Loss) income from operations | ||
| Other income (expense): | ||
| Interest income, net | ||
| Foreign currency transaction gain (loss) | ||
| Other income | ||
| Contingent gain on recovery of previously impaired assets | ||
| Other income (expense), net | ||
| Total other income, net | ||
| (Loss) income before income tax | ||
| Income tax (benefit) expense | ||
| Net (loss) income | ||
| Other comprehensive loss: | ||
| Foreign currency translation adjustment | ||
| Comprehensive (loss) income | ||
| (Loss) earnings per share – basic (in Dollars per share) | ||
| (Loss) earnings per share – diluted (in Dollars per share) | ||
| Weighted average number of ordinary shares outstanding – basic (in Shares) | ||
| Weighted average number of ordinary shares outstanding – diluted (in Shares) |
Loading...
